Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Other Non Operating Income of $107000.0 for Q1 2026, up 2775.0% on a QoQ basis from -$4000.0 in Q4 2025, and up 153.77% year-over-year from $42164.4 in Q1 2025.
Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $107000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 153.77% year-over-year to $107000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 233.78% YoY) and the FY2025 annual result came in at $700000.0, up 200.0% from the prior year.
- Other Non Operating Income was $107000.0 for Q1 2026 at Bicycle Therapeutics, up from -$4000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $745000.0 in Q2 2025 and bottomed at -$954000.0 in Q3 2024.
- A 3-year average of $36111.1 and a median of $101000.0 in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 637.62% in 2025, while the deepest fall reached 380.28% in 2025.
- Bicycle Therapeutics' Other Non Operating Income stood at $300000.0 in 2024, then plunged by 101.33% to -$4000.0 in 2025, then surged by 2775.0% to $107000.0 in 2026.
- Business Quant data shows BCYC's Other Non Operating Income at $107000.0 in Q1 2026, -$4000.0 in Q4 2025, and $158000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 745,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | -954,000.00 |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Jun 30, 2019 | -2.18 Mn |
| Mar 31, 2019 | -3.19 Mn |
| Dec 31, 2018 | 807,000.00 |
| Sep 30, 2018 | -1.36 Mn |
| Jun 30, 2018 | -73,000.00 |